2024-09-30 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates pharmacies, retail stores, and healthcare services, including pharmacy benefit management and health insurance.

**1. Performance Comparison:**

* **Cumulative Return:** CVS has underperformed the S&P 500 significantly, with a cumulative return of -31.94% compared to the S&P 500's 133.28%. 
* **Relative Divergence:** The current relative divergence is -165.22, indicating CVS is significantly lagging behind the S&P 500. This is in the bottom 1.36% of historical performance compared to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $61.75
* **5-Day Moving Average:** $58.98
* **20-Day Moving Average:** $58.00
* **60-Day Moving Average:** $58.31

The stock price has been trending upwards recently, moving above all three moving averages. This suggests potential short-term bullish momentum.

**3. Technical Indicators:**

* **RSI:** 76.04 (Overbought)
* **PPO:** 0.62 (Positive)
* **Delta_Previous_Relative_Divergence:** -1.14 (Short-term Downtrend)
* **Expected_Return:** 0.0% (Maximum 5-year estimated return on current invested funds)

The RSI indicates that the stock is currently overbought, suggesting potential for a pullback. The PPO indicates positive momentum, but the negative Delta_Previous_Relative_Divergence suggests a potential short-term downtrend. The low Expected Return highlights a possible lack of potential for substantial gains in the next five years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report for the quarter ending August 2024 showed an EPS of 1.83, exceeding the analyst expectation of 1.73. However, recent EPS has been fluctuating and showing a downward trend. This could be a cause for concern for investors. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** CVS's stock price has been fluctuating with recent news regarding the pharmacy benefit management industry and its competitive landscape. Some analysts believe that CVS's focus on providing integrated healthcare services and expanding its retail pharmacy network may be key growth drivers for the future.
* **Analyst Opinions:** Analysts are generally neutral on CVS, with some suggesting a potential for growth in the long term. However, some concerns remain regarding the company's profitability and competitive pressures.
* **Performance Highlights:** CVS has been facing challenges in its pharmacy benefit management business, facing lawsuits and scrutiny from regulators. However, the company has been making efforts to expand its retail footprint and provide integrated healthcare services.

**6. Conclusion:**

CVS is currently facing some challenges in the market. Its long-term performance has lagged significantly behind the S&P 500, and recent technical indicators suggest potential for a pullback in the short term. While the recent earnings report was positive, the overall EPS trend shows some volatility. CVS's future prospects depend on its ability to navigate the competitive healthcare landscape and successfully integrate its services. Investors should carefully consider these factors before making investment decisions.

**7. Report in English:**

## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates pharmacies, retail stores, and healthcare services, including pharmacy benefit management and health insurance.

**1. Performance Comparison:**

* **Cumulative Return:** CVS has underperformed the S&P 500 significantly, with a cumulative return of -31.94% compared to the S&P 500's 133.28%. 
* **Relative Divergence:** The current relative divergence is -165.22, indicating CVS is significantly lagging behind the S&P 500. This is in the bottom 1.36% of historical performance compared to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $61.75
* **5-Day Moving Average:** $58.98
* **20-Day Moving Average:** $58.00
* **60-Day Moving Average:** $58.31

The stock price has been trending upwards recently, moving above all three moving averages. This suggests potential short-term bullish momentum.

**3. Technical Indicators:**

* **RSI:** 76.04 (Overbought)
* **PPO:** 0.62 (Positive)
* **Delta_Previous_Relative_Divergence:** -1.14 (Short-term Downtrend)
* **Expected_Return:** 0.0% (Maximum 5-year estimated return on current invested funds)

The RSI indicates that the stock is currently overbought, suggesting potential for a pullback. The PPO indicates positive momentum, but the negative Delta_Previous_Relative_Divergence suggests a potential short-term downtrend. The low Expected Return highlights a possible lack of potential for substantial gains in the next five years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report for the quarter ending August 2024 showed an EPS of 1.83, exceeding the analyst expectation of 1.73. However, recent EPS has been fluctuating and showing a downward trend. This could be a cause for concern for investors. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** CVS's stock price has been fluctuating with recent news regarding the pharmacy benefit management industry and its competitive landscape. Some analysts believe that CVS's focus on providing integrated healthcare services and expanding its retail pharmacy network may be key growth drivers for the future.
* **Analyst Opinions:** Analysts are generally neutral on CVS, with some suggesting a potential for growth in the long term. However, some concerns remain regarding the company's profitability and competitive pressures.
* **Performance Highlights:** CVS has been facing challenges in its pharmacy benefit management business, facing lawsuits and scrutiny from regulators. However, the company has been making efforts to expand its retail footprint and provide integrated healthcare services.

**6. Conclusion:**

CVS is currently facing some challenges in the market. Its long-term performance has lagged significantly behind the S&P 500, and recent technical indicators suggest potential for a pullback in the short term. While the recent earnings report was positive, the overall EPS trend shows some volatility. CVS's future prospects depend on its ability to navigate the competitive healthcare landscape and successfully integrate its services. Investors should carefully consider these factors before making investment decisions. 
